NCT01591551 NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness Status COMPLETED Phase PHASE4
NCT01576887 A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis Status WITHDRAWN Phase PHASE2
NCT01568112 Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate Status COMPLETED Phase PHASE3
NCT01563562 Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function Status COMPLETED Phase PHASE1
NCT01561027 Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy Status COMPLETED Phase PHASE2
NCT01556685 MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia Status COMPLETED Phase PHASE4
NCT01552681 Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome Status TERMINATED Phase PHASE2
NCT01551446 Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes Status WITHDRAWN Phase PHASE1
NCT01549769 Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes Status TERMINATED Phase PHASE1
NCT01540630 A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia Status COMPLETED Phase PHASE2
NCT01538472 Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT01518920 A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss Status COMPLETED Phase PHASE1
NCT01518894 A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT01511510 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01503866 A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01500798 A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes Status TERMINATED Phase PHASE1
NCT01500408 Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers Status COMPLETED Phase PHASE1